First Light Asset Management, LLC Annexon, Inc. Transaction History

First Light Asset Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$2.73 - $11.94 $1.29 Million - $5.66 Million	-473,700 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$11.49 - $22.0 $115,738 - $221,606	-10,073 Reduced 2.08%	473,700 $5.44 Million
Q3 2021 Nov 12, 2021	BUY	$16.35 - $23.4 $4.54 Million - $6.5 Million	277,696 Added 134.75%	483,773 $9 Million
Q2 2021 Aug 13, 2021	BUY	$17.81 - $27.48 $3.67 Million - $5.66 Million	206,077 New	206,077 $4.64 Million

156

101M

3.73M

1.3M

Ticker ANNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,617,700
Market Cap $335M
Description
Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...

Get notified when there are updates to the investment portfolio of First Light Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on First Light Asset Management, LLC with notifications on news.